DexCom

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. 

CEO
Kevin Ronald Sayer
CEOKevin Ronald Sayer
Employees
10,300
Employees10,300
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1999
Founded1999
Employees
10,300
Employees10,300

DXCM Key Statistics

Market cap
33.74B
Market cap33.74B
Price-Earnings ratio
65.15
Price-Earnings ratio65.15
Dividend yield
Dividend yield
Average volume
2.75M
Average volume2.75M
High today
$87.24
High today$87.24
Low today
$85.81
Low today$85.81
Open price
$86.87
Open price$86.87
Volume
641.54K
Volume641.54K
52 Week high
$120.48
52 Week high$120.48
52 Week low
$57.52
52 Week low$57.52

DXCM News

Simply Wall St 2d
Should You Be Excited About DexCom, Inc.'s 24% Return On Equity?

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and...

Should You Be Excited About DexCom, Inc.'s 24% Return On Equity?

Analyst ratings

83%

of 29 ratings
Buy
82.8%
Hold
17.2%
Sell
0%

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.